MCTA
Charming Medical Limited
Price Chart
Latest Quote
$29.36
+0.00 (+0.00%)
Current Price
| Previous Close | $29.36 |
| Day High | $29.36 |
| Day Low | $29.36 |
Stock Information
| Shares Outstanding | 15.18M |
| Total Debt | $573K |
| Cash Equivalents | $2.69M |
| Revenue | $5.42M |
| Net Income | $657K |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Market Cap | $504.26M |
| P/E Ratio | 419.36 |
| EPS (TTM) | $0.07 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $448.13M |
| Sales | $5.42M |
| Income | $657K |
| Book/sh | $0.02 |
| Cash/sh | $0.18 |
| Employees | 49 |
Financial Ratios
| Quick Ratio | 0.57 |
| Current Ratio | 0.59 |
| Debt/Eq | 160.17 |
Returns & Margins
| ROA | 10.64% |
| Gross Margin | 96.02% |
| Operating Margin | -0.94% |
| Profit Margin | 12.12% |
Ownership
| Insider Ownership | 69.29% |
| Institutional Ownership | 0.28% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 92.98 |
| P/B | 1276.30 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $29.35 |
| SMA50 | $29.35 |
| RSI | nan |
| Shares Float | 4.31M |
| Short Float | 11.93% |
Performance History
| Week | +0.00% |
| Month | +0.00% |
| Quarter | +0.00% |
| 6 Months | +0.00% |
| YTD | +0.00% |
| 10 Years | +319.36% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-07-17 | $29.35 | 0 |
| 2026-07-16 | $29.35 | 0 |
| 2026-07-15 | $29.35 | 0 |
| 2026-07-14 | $29.35 | 0 |
| 2026-07-13 | $29.35 | 0 |
| 2026-07-10 | $29.35 | 0 |
| 2026-07-09 | $29.35 | 0 |
| 2026-07-08 | $29.35 | 0 |
| 2026-07-07 | $29.35 | 0 |
| 2026-07-06 | $29.35 | 0 |
| 2026-07-02 | $29.35 | 0 |
| 2026-07-01 | $29.35 | 0 |
| 2026-06-30 | $29.35 | 0 |
| 2026-06-29 | $29.35 | 0 |
| 2026-06-26 | $29.35 | 0 |
| 2026-06-25 | $29.35 | 0 |
| 2026-06-24 | $29.35 | 0 |
| 2026-06-23 | $29.35 | 0 |
| 2026-06-22 | $29.35 | 0 |
| 2026-06-18 | $29.35 | 0 |
About Charming Medical Limited
Charming Medical Limited, through its subsidiaries, engage in the provision of beauty, wellness, and postpartum services under the Beauty Lab brand name in Hong Kong. Its services includes womb-warming therapy, BTS (Beauty, Tailor-made, Slim) pelvic detox therapy, agarwood moxibustion therapy, traditional Chinese medicine (TCM)-inspired prenatal massage, and Indonesian traditional abdominal binding. The company also provides TCM-inspired supplements products, which includes Beauty Lab home herbal uterine care patch, probiotic intimate wash, and Yin nourishing pill sets; and beauty products, including ginseng soothing anti-allergy moisturizing wash for skin issues, and scalp health. In addition, it offers consultancy services to provide TCM-inspired therapy technical training and dietary therapy training to other well-established and reputable beauty salons, massage centers, and similar institutions. Further, the company's products are used for the treatment of alleviating premenstrual syndrome, menstrual irregularities, dysmenorrhea, leukorrhea, pelvic inflammatory disease, menopausal care, breast health, uterine health, enhance physical weakness, balance endocrine functions, and other common women's health issues. it operates wellness centres. The company was founded in 2016 and is headquartered in Causeway Bay, Hong Kong.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|
| Revenue | |||
| Reconciled Cost Of Revenue | $2,041,363 | $2,101,389 | $2,036,940 |
| Cost Of Revenue | $2,041,363 | $2,101,389 | $2,036,940 |
| Total Revenue | $6,221,751 | $6,015,375 | $3,530,822 |
| Operating Revenue | $6,221,751 | $6,015,375 | $3,530,822 |
| Expenses | |||
| Interest Expense | $20,874 | $26,051 | $20,259 |
| Total Expenses | $4,606,639 | $4,841,419 | $3,818,320 |
| Rent Expense Supplemental | $711,716 | $848,691 | $647,617 |
| Other Income Expense | $-12,519 | $-214 | $19,312 |
| Other Non Operating Income Expenses | $-15,140 | $-214 | $19,312 |
| Net Non Operating Interest Income Expense | $-167,426 | $-170,248 | $-152,282 |
| Total Other Finance Cost | $210,688 | $163,710 | $142,311 |
| Interest Expense Non Operating | $20,874 | $26,051 | $20,259 |
| Operating Expense | $2,565,276 | $2,740,030 | $1,781,380 |
| Other Operating Expenses | $-15,486 | $-1,398 | $-91,527 |
| Selling And Marketing Expense | $999,354 | $859,473 | $664,882 |
| General And Administrative Expense | $1,317,954 | $1,490,251 | $996,947 |
| Income & Earnings | |||
| Net Income From Continuing Operation Net Minority Interest | $1,199,085 | $777,811 | $-305,117 |
| Net Interest Income | $-167,426 | $-170,248 | $-152,282 |
| Interest Income | $64,136 | $19,513 | $10,288 |
| Normalized Income | $1,196,894 | $777,811 | $-305,117 |
| Net Income From Continuing And Discontinued Operation | $1,199,085 | $777,811 | $-305,117 |
| Total Operating Income As Reported | $1,388,938 | $1,008,848 | $-521,336 |
| Net Income Common Stockholders | $1,199,085 | $777,811 | $-305,117 |
| Net Income | $1,199,085 | $777,811 | $-305,117 |
| Net Income Including Noncontrolling Interests | $1,199,085 | $821,743 | $-335,605 |
| Net Income Continuous Operations | $1,199,085 | $821,743 | $-335,605 |
| Pretax Income | $1,435,167 | $1,003,494 | $-420,468 |
| Interest Income Non Operating | $64,136 | $19,513 | $10,288 |
| Operating Income | $1,615,112 | $1,173,956 | $-287,498 |
| Depreciation Amortization Depletion Income Statement | $263,454 | $391,704 | $211,078 |
| Depreciation And Amortization In Income Statement | $263,454 | $391,704 | $211,078 |
| Depreciation Income Statement | $263,454 | $391,704 | $211,078 |
| Gross Profit | $4,180,388 | $3,913,986 | $1,493,882 |
| Per Share | |||
| Diluted EPS | - | $0.05 | $-0.02 |
| Basic EPS | - | $0.05 | $-0.02 |
| Other | |||
| Tax Effect Of Unusual Items | $430 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $1,716,874 | $1,421,249 | $-189,131 |
| Total Unusual Items | $2,621 | - | - |
| Total Unusual Items Excluding Goodwill | $2,621 | - | - |
| Reconciled Depreciation | $263,454 | $391,704 | $211,078 |
| EBITDA (Bullshit earnings) | $1,719,495 | $1,421,249 | $-189,131 |
| EBIT | $1,456,041 | $1,029,545 | $-400,209 |
| Diluted NI Availto Com Stockholders | $1,199,085 | $777,811 | $-305,117 |
| Minority Interests | $0 | $-43,932 | $30,488 |
| Tax Provision | $236,082 | $181,751 | $-84,863 |
| Gain On Sale Of Security | $2,621 | - | - |
| Selling General And Administration | $2,317,308 | $2,349,724 | $1,661,829 |
| Other Gand A | $606,238 | $641,560 | $349,330 |
| Rent And Landing Fees | $711,716 | $848,691 | $647,617 |
| Diluted Average Shares | - | $16,938,000 | $16,938,000 |
| Basic Average Shares | - | $16,938,000 | $16,938,000 |
Fetched: 2026-07-15
Balance Sheet (Annual)
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|
| Assets | |||
| Net Tangible Assets | $49,243 | $-1,079,439 | $-1,158,610 |
| Total Assets | $5,355,741 | $4,881,870 | $6,384,238 |
| Total Non Current Assets | $1,988,530 | $1,214,443 | $2,264,363 |
| Non Current Prepaid Assets | $128,290 | $54,604 | $193,753 |
| Non Current Deferred Assets | $649,645 | $237,978 | $272,774 |
| Non Current Deferred Taxes Assets | $77,293 | $211,144 | $272,774 |
| Current Assets | $3,367,211 | $3,667,427 | $4,119,875 |
| Inventory | $26,797 | $28,151 | $66,332 |
| Receivables | $579,091 | $1,535,621 | $2,124,351 |
| Other Receivables | $183,190 | $298,951 | $120,536 |
| Accounts Receivable | $395,901 | $351,614 | $186,638 |
| Allowance For Doubtful Accounts Receivable | $0 | $0 | $0 |
| Gross Accounts Receivable | $395,901 | $351,614 | $186,638 |
| Cash Cash Equivalents And Short Term Investments | $2,761,323 | $2,103,655 | $1,929,192 |
| Cash And Cash Equivalents | $816,771 | $2,103,655 | $1,929,192 |
| Cash Financial | - | $2,103,655 | $1,929,192 |
| Debt | |||
| Total Debt | $1,160,639 | $961,379 | $1,809,514 |
| Long Term Debt And Capital Lease Obligation | $358,033 | $148,250 | $484,258 |
| Current Debt And Capital Lease Obligation | $802,606 | $813,129 | $1,325,256 |
| Current Debt | $314,226 | $442,612 | $589,659 |
| Liabilities | |||
| Total Liabilities Net Minority Interest | $5,306,498 | $6,027,938 | $7,653,061 |
| Total Non Current Liabilities Net Minority Interest | $358,033 | $148,250 | $484,258 |
| Current Liabilities | $4,948,465 | $5,879,688 | $7,168,803 |
| Current Deferred Liabilities | $3,463,453 | $4,496,155 | $5,602,672 |
| Payables And Accrued Expenses | $682,406 | $570,404 | $240,875 |
| Payables | $476,124 | $159,259 | $12,802 |
| Other Payable | $36,702 | $40,005 | $11,230 |
| Total Tax Payable | $221,339 | $119,254 | $0 |
| Accounts Payable | $3,480 | $0 | $1,572 |
| Equity | |||
| Common Stock Equity | $49,243 | $-1,079,439 | $-1,158,610 |
| Total Equity Gross Minority Interest | $49,243 | $-1,146,068 | $-1,268,823 |
| Stockholders Equity | $49,243 | $-1,079,439 | $-1,158,610 |
| Other Equity Interest | $-381,043 | $-381,043 | $-381,043 |
| Gains Losses Not Affecting Retained Earnings | $-3,569 | $205 | $3,923 |
| Other Equity Adjustments | $-3,569 | $205 | $3,923 |
| Retained Earnings | $119,441 | $-1,079,644 | $-1,162,533 |
| Other | |||
| Ordinary Shares Number | $16,938,000 | $16,938,000 | $16,938,000 |
| Share Issued | $16,938,000 | $16,938,000 | $16,938,000 |
| Tangible Book Value | $49,243 | $-1,079,439 | $-1,158,610 |
| Invested Capital | $363,469 | $-636,827 | $-568,951 |
| Working Capital | $-1,581,254 | $-2,212,261 | $-3,048,928 |
| Capital Lease Obligations | $846,413 | $518,767 | $1,219,855 |
| Total Capitalization | $49,243 | $-1,079,439 | $-1,158,610 |
| Minority Interest | $0 | $-66,629 | $-110,213 |
| Additional Paid In Capital | $312,880 | $379,509 | $379,509 |
| Capital Stock | $1,534 | $1,534 | $1,534 |
| Common Stock | $1,534 | $1,534 | $1,534 |
| Long Term Capital Lease Obligation | $358,033 | $148,250 | $484,258 |
| Current Deferred Revenue | $3,463,453 | $4,496,155 | $5,602,672 |
| Current Capital Lease Obligation | $488,380 | $370,517 | $735,597 |
| Line Of Credit | $314,226 | $442,612 | $589,659 |
| Current Accrued Expenses | $206,282 | $411,145 | $228,073 |
| Dueto Related Parties Current | $214,603 | $0 | - |
| Net PPE | $1,210,595 | $921,861 | $1,797,836 |
| Accumulated Depreciation | $-2,001,503 | $-1,587,529 | $-1,123,569 |
| Gross PPE | $3,212,098 | $2,509,390 | $2,921,405 |
| Leases | $724,398 | $798,533 | $752,410 |
| Machinery Furniture Equipment | $659,469 | $369,273 | $201,909 |
| Buildings And Improvements | $1,828,231 | $1,341,584 | $1,967,086 |
| Properties | $0 | $0 | $0 |
| Duefrom Related Parties Current | $0 | $885,056 | $1,817,177 |
| Other Short Term Investments | $1,944,552 | $0 | - |
Fetched: 2026-07-15
Cash Flow Statement (Annual)
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|
| Free Cash Flow | |||
| Free Cash Flow | $138,361 | $84,831 | $1,827,609 |
| Operating Activities | |||
| Operating Cash Flow | $425,888 | $295,429 | $2,433,803 |
| Cash Flow From Continuing Operating Activities | $425,888 | $295,429 | $2,433,803 |
| Investing Activities | |||
| Capital Expenditure | $-287,527 | $-210,598 | $-606,194 |
| Investing Cash Flow | $-2,229,458 | $-210,598 | $-606,194 |
| Cash Flow From Continuing Investing Activities | $-2,229,458 | $-210,598 | $-606,194 |
| Financing Activities | |||
| Financing Cash Flow | $521,303 | $100,145 | $-1,430,278 |
| Cash Flow From Continuing Financing Activities | $521,303 | $100,145 | $-1,430,278 |
| Net Other Financing Charges | $472,374 | $215,996 | $-1,252,359 |
| Other | |||
| Repayment Of Debt | $-156,937 | $-154,192 | $-177,919 |
| Issuance Of Debt | $205,866 | $38,341 | $0 |
| Interest Paid Supplemental Data | $20,874 | $26,051 | $20,259 |
| End Cash Position | $816,771 | $2,103,655 | $1,929,192 |
| Beginning Cash Position | $2,103,655 | $1,929,192 | $1,526,204 |
| Effect Of Exchange Rate Changes | $-4,617 | $-10,513 | $5,657 |
| Changes In Cash | $-1,282,267 | $184,976 | $397,331 |
| Net Issuance Payments Of Debt | $48,929 | $-115,851 | $-177,919 |
| Net Short Term Debt Issuance | $-130,783 | $-148,881 | $-177,919 |
| Short Term Debt Payments | $-130,783 | $-148,881 | $-177,919 |
| Net Long Term Debt Issuance | $179,712 | $33,030 | $0 |
| Long Term Debt Payments | $-26,154 | $-5,311 | $0 |
| Long Term Debt Issuance | $205,866 | $38,341 | $0 |
| Net Investment Purchase And Sale | $-1,941,931 | $0 | - |
| Purchase Of Investment | $-1,941,931 | $0 | - |
| Net PPE Purchase And Sale | $-287,527 | $-210,598 | $-606,194 |
| Purchase Of PPE | $-287,527 | $-210,598 | $-606,194 |
| Change In Working Capital | $-1,160,637 | $-943,049 | $2,497,432 |
| Change In Other Working Capital | $-1,057,178 | $-1,106,517 | $2,640,751 |
| Change In Payables And Accrued Expense | $-102,601 | $329,529 | $180,403 |
| Change In Payable | $-102,601 | $329,529 | $180,403 |
| Change In Account Payable | $-204,686 | $210,275 | $180,403 |
| Change In Tax Payable | $102,085 | $119,254 | $0 |
| Change In Income Tax Payable | $102,085 | $119,254 | $0 |
| Change In Prepaid Assets | $42,075 | $-39,266 | $-113,831 |
| Change In Inventory | $1,354 | $38,181 | $-55,873 |
| Change In Receivables | $-44,287 | $-164,976 | $-154,018 |
| Changes In Account Receivables | $-44,287 | $-164,976 | $-154,018 |
| Other Non Cash Items | $-8,266 | $-37,446 | $60,898 |
| Unrealized Gain Loss On Investment Securities | $-2,621 | $0 | - |
| Deferred Tax | $134,873 | $62,477 | - |
| Deferred Income Tax | $134,873 | $62,477 | - |
| Depreciation Amortization Depletion | $263,454 | $391,704 | $211,078 |
| Depreciation And Amortization | $263,454 | $391,704 | $211,078 |
| Depreciation | $263,454 | $391,704 | $211,078 |
| Net Income From Continuing Operations | $1,199,085 | $821,743 | $-335,605 |
Fetched: 2026-07-15